http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04360696-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c7159366be37ecf8a4c595cfa235a8
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
filingDate 1991-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_204dd279acfff1c71649b0ac454f3226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5de01461c1d2285a1540d4b094e8a461
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9789e64b92e321afd775bb49e9521977
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c356521912a0e45dae6096db942c9fbb
publicationDate 1992-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04360696-A
titleOfInvention Recombinant human antibody produced with new human b lymphocyte strain as host
abstract PURPOSE: To provide a new antibody-nonproductive cell strain to be used for producing IgM or IgA antibody containing human J-chain protein. n CONSTITUTION: The objective antibody-nonproductive cell strain, which does not produce endogenous antibody and H-chain and L-chain as its constituents, obtained by introducing exogenous antibody gene into namaruba cell strain assimilated to a serumless medium. Specifically, antibody-nonproductive mutant cell strain is first obtained, by X-ray irradiation or using a mutating chemical, from the namaruba cells (ATCC CRL 1432) of human B lymphocyte strain, pref. NKG4 strain, and said mutant cell strain is put to cloning using a serumless medium to enable said strain to be cultured in such serumless medium, thus obtaining the objective antibody-nonproductive cell strain sensitive to amidoglycoside-based antibiotic G-418 or mycophenolic acid. n COPYRIGHT: (C)1992,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8920797-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2005005636-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8257703-B2
priorityDate 1991-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506748
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415824599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396525
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446541

Total number of triples: 32.